Shares of Sareum Holdings plc (LON:SAR – Get Free Report) crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of GBX 23.95 ($0.30) and traded as low as GBX 23.75 ($0.29). Sareum shares last traded at GBX 33.50 ($0.41), with a volume of 5,873,998 shares traded.
Sareum Price Performance
The company’s 50-day simple moving average is GBX 23.95 and its 200-day simple moving average is GBX 46.70. The stock has a market capitalization of £22.56 million, a price-to-earnings ratio of -650.00 and a beta of -0.69.
About Sareum
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor that is in a Phase 1a clinical trials for the treatment of autoimmune diseases.
Read More
- Five stocks we like better than Sareum
- Investing in Construction Stocks
- Charles Schwab Fortifies its Uptrend on EPS Beat
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Lockheed Martin Stock Aims for a Fresh All-Time High
- Comparing and Trading High PE Ratio Stocks
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Sareum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sareum and related companies with MarketBeat.com's FREE daily email newsletter.
